Key facts
- It has raised $5.0M across 1 recorded rounds; the latest was Seed Round ($3.7M) in Jun 2021.
- Notable investors include Foresight Canada, Mitacs.
- Kisolite has filed 5 Form Ds with the SEC since 2018, most recently May 2024 ($10K sold to 1 investors).
- Status: Privately Held (backing).
Investors
2- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Kisolite
Funding rounds
1 roundsAbout Kisolite
Operator of a bioactive mineral research company intended to validate potential products for unmet global health needs scientifically. The company offers mineral clay that is free from contaminants and untainted by marine waste and environmental pollutants, which helps in healing skin irritation and internal ailments, and is an active ingredient for skincare emulsification and formulas, enabling people to avoid harsh chemicals, cleaners, and disinfectants that are not beneficial for their skin and get a positive effect on their overall health and well-being.
- Sector
- Healthcare
- HQ
- Vancouver, Canada
- Founded
- 2011
- Employees
- 6
- Website
- kisolite.com/
- Ownership
- Privately Held (backing)
Kisolite doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kisolite shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kisolite in its N-PORT filings yet. We sweep new filings monthly.